Better Therapeutics Inc (BTTX) reports earnings on August 12. Lets take a closer look at how this biotech stock is currently trading.
Analysts are estimating Better Therapeutics Inc will report an EPS (earnings per share) of -$0.42. Over the last 90 days, analysts have lowered estimates onece and raised them once, implying there is some uncertainty in the estimate.
Share price moves can have an impact on existing shareholder sentiment. As of August 04 shares of BTTX are trading at $2.14. Over the last 52-week period, the price is down -92.72%.
Better Therapeutics Inc bulls will obviously be hoping that the earnings report beats the analysts' estimates. But they'll also want to hear that the earnings beat was on higher than expected revenues. Finally, they'll want the company to paint a picture that leads analysts to conclude this is just the start of an exciting growth story.
Bears are one of the most intelligent land animals in North America. Which is why they'll be listening for news that the company misses on EPS, Revenues, or future guidance. They will look to push a negative growth story for the stock in the coming quarters, and will gain more traction in a generally down market as opposed a market that is generally trending upwards.
If you haven't traded too many earnings reports, it's important to be aware that a stock's price movement can be caused by a change in the analysts' estimates based on the Q&A from the conference call with management discussing the earnings report. As you see more of these reports, your ability to recognize changes in investor sentiment will improve.